WO2012159444A1 - Acupoint injection - Google Patents

Acupoint injection Download PDF

Info

Publication number
WO2012159444A1
WO2012159444A1 PCT/CN2012/000614 CN2012000614W WO2012159444A1 WO 2012159444 A1 WO2012159444 A1 WO 2012159444A1 CN 2012000614 W CN2012000614 W CN 2012000614W WO 2012159444 A1 WO2012159444 A1 WO 2012159444A1
Authority
WO
WIPO (PCT)
Prior art keywords
phenol
saturated solution
injection
cases
treatment
Prior art date
Application number
PCT/CN2012/000614
Other languages
French (fr)
Chinese (zh)
Inventor
李跃华
Original Assignee
Li Yuehua
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Li Yuehua filed Critical Li Yuehua
Publication of WO2012159444A1 publication Critical patent/WO2012159444A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A61H39/08Devices for applying needles to such points, i.e. for acupuncture ; Acupuncture needles or accessories therefor
    • A61H39/086Acupuncture needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/10Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
    • A61H2201/105Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy with means for delivering media, e.g. drugs or cosmetics

Definitions

  • acupuncture treatment is a commonly used treatment method since ancient times. It mainly uses some diseases of the book corresponding to various acupoints of the human body for acupuncture, although it has certain curative effect on many diseases, but It is slow, and in many cases it cannot be completely cured. Especially for some chronic inflammations such as: chronic rhinitis, chronic pharyngitis, repeated tonsil suppuration, stomach disease, cervical spondylosis, lumbar disc herniation, arthritis, etc.; there are also some viral diseases such as: oral-genital herpes, herpes zoster, etc. Etc. Even acupuncture does not have a good effect, and there are no other treatments at present.
  • Phenol also known as “carbonic acid”
  • carbonic acid is prepared by hydrolysis of chlorobenzene or oxidation of cumene; it is an important raw material for organic synthesis, and is mostly used in the manufacture of plastics, medicines, pesticides, dyes, etc., and is commonly used as antiseptic in medicine.
  • a bactericide rarely used as a medicine to treat a disease, even if it is used as a medicine, it is formulated together with other medicines as a topical medicine. Summary of the invention It is an object of the present invention to provide an acupoint injection for treating various diseases by using a saturated solution of phenol in combination with acupoints. 5 ⁇ 2: 100 ⁇ The mixture of a mixture of the above-mentioned ingredients is 0.
  • composition of the composition further comprises a 2% lidocaine, a saturated solution at room temperature, a saline solution and a 2% lidocaine mixture ratio of 0. 5 ⁇ 2: 100: 5.
  • the mixing ratio of the saturated solution of phenol, physiological saline and lidocaine is 0. 5 ⁇ 1. 5 : 100 : 5.
  • the mixing ratio of phenol at room temperature to saturated solution, physiological saline and lidocaine is 1:100:5.
  • phenol is the main therapeutic drug, and a saturated solution of phenol at normal temperature is used, and diluted into physiological saline, the content of phenol is very small, and does not cause harm to the human body, but the effect is huge, by injection.
  • This medicine stimulates the functions of acupoints, strengthens them, enhances the curative effect, and achieves the purpose of curing diseases. Its curative effect is fast and effective. It can cure a variety of diseases that cannot be cured by many current methods. There is no side effect other than pain. Adding lidocaine can reduce the pain of acupoint injection.
  • An acupoint injection consisting of the following components: a saturated solution of phenol at room temperature 0. 5ml, 2% lidocaine 5ml. physiological saline 100ml.
  • Preparation method 0.5 ml of a saturated solution of phenol at room temperature and 5 ml of 2% lidocaine are dissolved in 100 ml of physiological saline, and uniformly mixed.
  • Clinical application Treatment of recurrent suppurative tonsillitis and tonsil enlargement.
  • Treatment Take the patient's bilateral Futian points, each point is injected with 1ml of the drug, once a day, the second 2-3 days of fever, the disappearance of the suppuration point on the tonsils on the 5th-7th day; adults can swollen tonsils after one year Shrink Small or even disappeared, children can see the tonsils shrink or even disappear after puberty. Adults and children have no or little tonsil inflammation and suppuration after 7 days of treatment, avoiding the trouble of surgical removal of tonsils.
  • An acupoint injection consisting of the following components: a saturated solution of phenol at room temperature 1 ml, 2% lidocaine 5 ml, and physiological saline 100 ml.
  • Preparation method 1 ml of a saturated solution of phenol at room temperature and 5 ml of 2% lidocaine are dissolved in 100 ml of physiological saline, and uniformly mixed.
  • Clinical application Treatment of chronic rhinitis.
  • Treatment method Take the patient's two Yingxiang points, respectively, and inject the above formula to get 0. 5ml, 1-3 times a week, after 5 times of injection, change to once a month, 5 times, and once every 2 months. , the whole year and a half. Most patients are cured within two months, and a small number of patients require a full course of treatment.
  • Treatment results 65 cases were cured, 31 cases were effective, 4 cases were ineffective; the cure rate reached 65%, and the effective rate reached 96%.
  • An acupoint injection consisting of the following components: a saturated solution of phenol at room temperature 1. 5 ml, 2% lidocaine 5 ml, physiological saline 100 ml.
  • Preparation method 1.5 ml of phenol in a saturated solution at room temperature and 5 ml of 2% lidocaine dissolved in 100 ml of physiological saline, and mixed well.
  • Clinical application treatment of cervical spondylosis
  • Treatment method Take the patient's Dazhui point and two paravertebral points and Ashi points, each acupuncture point injection of 0. 5ml of the drug, 1 time / daily - 1 time / week, after five times, changed to monthly, a total of 20-30 times, in which the healer can stop treatment at any time, and severe cases need to be injected 30 times.
  • Treatment results 45 cases were cured, 12 cases were effective, 3 cases were ineffective, the cure rate was 75%, and the effective rate was reached.
  • An acupoint injection consisting of the following components: a saturated solution of phenol at room temperature 2 ml, 2% lidocaine 5 ml, and physiological saline 100 ml.
  • Preparation method 2 ml of phenol in a saturated solution at room temperature and 5 ml of 2% lidocaine dissolved in 100 ml of physiological saline, and mixed well.
  • Clinical application Treatment of herpes zoster.
  • Treatment method Take the patient's acupuncture points, that is, the herpes, and inject the above formula into the medicine.
  • 5-lml o can inject 10 acupuncture points at a time, that is, the total injection volume reaches 10-30ml, once a day, treatment to the third -4 days, the pain was relieved, herpes began to dry and dry, and by the 7th day, the skin of the herpes returned to normal, and the drug was stopped. By 14 days, the pain completely disappeared.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An acupoint injection, the components whereof comprise a saturated solution of phenol at normal temperature and saline mixed at a ratio of 0.5 to 2 : 100. The injection employs phenol in the form of a saturated solution at normal temperature and diluted in the saline. The injection stimulates the original functions of an acupoint and enhances same, thereby improving the therapeutic effectiveness, and achieving the purpose of curing diseases.

Description

一种穴位注射剂  Acupoint injection
技术领域 Technical field
本发明的目的是提供一种注射药物, 具体是一种穴位注射剂。  It is an object of the present invention to provide an injectable drug, in particular a acupoint injection.
说 背景技术  Background technology
目前有很多疾病都无法治愈, 而针灸治疗是从古至今比较常用的一种治 疗方式, 它主要利用人体的各个穴位所对应书的一些病症来进行针灸, 虽然对 很多病症有一定的疗效, 但是其见效慢, 而且很多情况下并不能完全治愈。 特别是对于一些慢性炎症如: 慢性鼻炎、 慢性咽喉炎、 反复扁桃体化脓、 胃 病、 颈椎病、 腰椎间盘突出、 关节炎等等; 还有一些病毒性疾病如: 口腔-生 殖器疱疹、 带状疱疹等等, 即使是针灸也没有很好的疗效, 而且目前也没有 其它的治疗方法。 医学文献上对于穴位治疗的记载有很多, 通过穴位治疗的 方法除了针灸, 也有一些穴位注射配方, 可是每种配方都是有多种药物配制, 其配制复杂, 治疗效果一般, 而且大多是单独针对某种疾病配制, 目前并没 有见过用同一种配方来治疗多种疾病的方法。  At present, many diseases cannot be cured, and acupuncture treatment is a commonly used treatment method since ancient times. It mainly uses some diseases of the book corresponding to various acupoints of the human body for acupuncture, although it has certain curative effect on many diseases, but It is slow, and in many cases it cannot be completely cured. Especially for some chronic inflammations such as: chronic rhinitis, chronic pharyngitis, repeated tonsil suppuration, stomach disease, cervical spondylosis, lumbar disc herniation, arthritis, etc.; there are also some viral diseases such as: oral-genital herpes, herpes zoster, etc. Etc. Even acupuncture does not have a good effect, and there are no other treatments at present. There are many records on acupoint treatment in the medical literature. In addition to acupuncture, there are some acupoint injection formulations. However, each formula is formulated with multiple drugs. The preparation is complicated, the treatment effect is general, and most of them are directed to each other. For the preparation of certain diseases, no method has been seen to treat multiple diseases with the same formula.
"苯酚", 亦称 "石炭酸", 由氯苯水解或异丙苯氧化等方法制备; 是有 机合成的重要原料, 多用于制造塑料、 医药、 农药、 染料等, 而在医药上常 用来作为防腐杀菌剂, 很少用来作为药剂治疗疾病, 即使用来作为药剂, 也 是和其它多种药物配制在一起作为外用药。 发明内容 本发明的目的是提供一种利用苯酚的饱和溶液配合穴位治疗多种疾病的 穴位注射剂。 所述一种穴位注射剂, 其组成成分包括苯酚在常温下的饱和溶液和生理 盐水, 上述成分的混合比例为 0. 5〜2: 100。 所述组成成分还包括 2%的利多卡因, 常温下的饱和溶液、 生理盐水和 2% 的利多卡因混合比例为 0. 5〜2: 100: 5。 所述苯酚在常温下的饱和溶液、生理盐水和利多卡因的混合比例为 0. 5〜 1. 5 : 100 : 5。 苯酚在常温下的饱和溶液、生理盐水和利多卡因的混合比例为 1 : 100: 5。 本发明在具体治疗某种疾病时, 按照针灸的取穴原则, 在相应穴位注射 穴位注射剂 0. 3-lml , 视病人、 病情、 病种不同, 每日 1次一每周一次; 视 病程、 病种、 病人具体情况不同 1-30次治愈。 原则上针灸可以治疗的病大都 可以用本发明来进行穴位注射治疗, 并可取得很好的疗效。 本发明中苯酚为主要的治疗药品, 而且采用的是苯酚在常温下的饱和溶 液, 并稀释到生理盐水中, 苯酚的含量非常少, 并不会对人体造成危害, 但 其效果巨大, 通过注射本药, 激发穴位原本具有的功能, 使其强化, 增强疗 效, 达到治愈疾病的目的。 其疗效好、 见效快, 可以治愈多种目前很多方法 都不能治愈的疾病, 除了疼痛外并不存在什么副作用, 加入利多卡因便可减 轻穴位注射的疼痛。 "Phenol", also known as "carbonic acid", is prepared by hydrolysis of chlorobenzene or oxidation of cumene; it is an important raw material for organic synthesis, and is mostly used in the manufacture of plastics, medicines, pesticides, dyes, etc., and is commonly used as antiseptic in medicine. A bactericide, rarely used as a medicine to treat a disease, even if it is used as a medicine, it is formulated together with other medicines as a topical medicine. Summary of the invention It is an object of the present invention to provide an acupoint injection for treating various diseases by using a saturated solution of phenol in combination with acupoints. 5〜2: 100。 The mixture of a mixture of the above-mentioned ingredients is 0. 5~2: 100. 5〜2: 100: 5。 The composition of the composition further comprises a 2% lidocaine, a saturated solution at room temperature, a saline solution and a 2% lidocaine mixture ratio of 0. 5~2: 100: 5. 5〜 1. 5 : 100 : 5。 The mixing ratio of the saturated solution of phenol, physiological saline and lidocaine is 0. 5~ 1. 5 : 100 : 5. The mixing ratio of phenol at room temperature to saturated solution, physiological saline and lidocaine is 1:100:5. In the specific treatment of a certain disease, in accordance with the acupoint selection principle of acupuncture, inject acupoint injections at the corresponding acupoints 0. 3-lml, depending on the patient, the condition, the disease type, once a day once a week; depending on the course of disease, The disease and patient's specific conditions are different from 1 to 30 times. In principle, most of the diseases that can be treated by acupuncture can be treated by acupoint injection with the present invention, and a good therapeutic effect can be obtained. In the present invention, phenol is the main therapeutic drug, and a saturated solution of phenol at normal temperature is used, and diluted into physiological saline, the content of phenol is very small, and does not cause harm to the human body, but the effect is huge, by injection. This medicine stimulates the functions of acupoints, strengthens them, enhances the curative effect, and achieves the purpose of curing diseases. Its curative effect is fast and effective. It can cure a variety of diseases that cannot be cured by many current methods. There is no side effect other than pain. Adding lidocaine can reduce the pain of acupoint injection.
为了证明本发明中注射剂的优点, 本发明以实施例中的药剂进行了临床 试验, 结果如下:  In order to demonstrate the advantages of the injection of the present invention, the present invention has been clinically tested with the agents of the examples, and the results are as follows:
一、 自 2004年至 2011年, 先后在湖南省宁远县博爱医院、 四川省南充 市武警支队医院、 湖南省祁东县疾病控制中心门诊部以及湖北省武汉市军事 经济学院门诊部进行临床试验, 治疗了近万例病人。 对慢性鼻炎、 慢性鼻窦 炎、 腰椎间盘突出、 带状疱疹和早期痔引起的便血及割痔手术后恢复与防止 复发等病人共 800例进行临床观察, 年龄 2岁 -89岁。 1. From 2004 to 2011, it was successively in Bo'ai Hospital of Ningyuan County, Hunan Province, Armed Police Detachment Hospital of Nanchong City, Sichuan Province, Outpatient Department of Qidong County Disease Control Center of Hunan Province, and Wuhan Military Department of Hubei Province. The outpatient department of the School of Economics conducted clinical trials and treated nearly 10,000 patients. Clinical observation of 800 patients with chronic rhinitis, chronic sinusitis, lumbar disc herniation, herpes zoster and early sputum caused by blood in the stool and recovery after resection and prevention of recurrence, aged 2 to 89 years old.
二、 疗效评判标准:  Second, the efficacy evaluation criteria:
1 . 治愈标准: 临床症状全部消失, 观察半年无复发;  1. Cure criteria: All clinical symptoms disappeared, and no recurrence was observed for half a year;
2. 有效标准: 临床症状部分消失或减轻, 半年内有复发;  2. Effective criteria: Some of the clinical symptoms disappear or are alleviated, and there is a recurrence within half a year;
3. 无效标准: 临床症状无改变。 三、 结果: 治愈 488例, 治愈率 61%; 有效 192例, 有效率 85%; 无效 120 例, 无效率 15%。 需要说明的是: 其中无效的病人都是治疗不满五次, 并没有 完成治疗。 具体实施方式  3. Invalid criteria: No change in clinical symptoms. Third, the results: 488 cases were cured, the cure rate was 61%; effective 192 cases, the effective rate was 85%; 120 cases were invalid, the inefficiency was 15%. It should be noted that: Invalid patients are treated less than five times and have not completed treatment. detailed description
下面结合实施例对本发明作进一步说明。  The invention is further illustrated by the following examples.
实施例 1  Example 1
一种穴位注射剂, 由以下组分组成: 苯酚在常温下的饱和溶液 0. 5ml, 2% 利多卡因 5ml . 生理盐水 100ml。  An acupoint injection consisting of the following components: a saturated solution of phenol at room temperature 0. 5ml, 2% lidocaine 5ml. physiological saline 100ml.
制备方法: 将 0. 5ml的苯酚在常温下的饱和溶液和 5ml的 2%利多卡因溶 入 100ml的生理盐水中, 混合均匀即可。 临床应用: 治疗反复发作的化脓性扁桃体炎及扁桃体肿大。  Preparation method: 0.5 ml of a saturated solution of phenol at room temperature and 5 ml of 2% lidocaine are dissolved in 100 ml of physiological saline, and uniformly mixed. Clinical application: Treatment of recurrent suppurative tonsillitis and tonsil enlargement.
自 2004年以来, 用以上配方的注射药剂治愈了反复发作的化脓性扁桃体 炎及扁桃体肿大病人 38例, 临床观察 38例, 年龄 2-35岁。  Since 2004, 38 patients with recurrent suppurative tonsillitis and tonsil enlargement have been treated with the above-mentioned injections, and 38 cases have been clinically observed, aged 2-35 years.
治疗方法: 取患者双侧扶突穴, 每个穴位注射 1ml 药剂, 每日一次, 第 2-3天退烧, 第 5-7天扁桃体上化脓点消失; 成人可于一年后肿大的扁桃体缩 小甚至消失不见, 儿童可在青春期后看见扁桃体缩小甚至消失, 成人和儿童 均在治疗 7天后不再或很少出现扁桃体发炎化脓现象, 避免了手术摘除扁桃 体的麻烦。 Treatment: Take the patient's bilateral Futian points, each point is injected with 1ml of the drug, once a day, the second 2-3 days of fever, the disappearance of the suppuration point on the tonsils on the 5th-7th day; adults can swollen tonsils after one year Shrink Small or even disappeared, children can see the tonsils shrink or even disappear after puberty. Adults and children have no or little tonsil inflammation and suppuration after 7 days of treatment, avoiding the trouble of surgical removal of tonsils.
治疗结果: 38例全部治愈, 治愈率 100%。  Treatment results: All 38 cases were cured, and the cure rate was 100%.
实施例 2  Example 2
一种穴位注射剂, 由以下组分组成: 苯酚在常温下的饱和溶液 lml, 2% 利多卡因 5ml, 生理盐水 100ml。  An acupoint injection consisting of the following components: a saturated solution of phenol at room temperature 1 ml, 2% lidocaine 5 ml, and physiological saline 100 ml.
制备方法: 将 1ml的苯酚在常温下的饱和溶液和 5ml的 2%利多卡因溶入 100ml的生理盐水中, 混合均匀即可。  Preparation method: 1 ml of a saturated solution of phenol at room temperature and 5 ml of 2% lidocaine are dissolved in 100 ml of physiological saline, and uniformly mixed.
临床应用: 治疗慢性鼻炎。  Clinical application: Treatment of chronic rhinitis.
自 2004午以来, 用以上配方的注射药剂治疗了慢性鼻炎两干多例, 临床 观察 100例, 年龄 6-70岁。  Since the afternoon of 2004, more than two cases of chronic rhinitis have been treated with the above-mentioned injections, and 100 cases have been clinically observed, aged 6-70 years.
治疗方法: 取病人两个迎香穴, 分别注射以上配方所得药剂 0. 5ml, 每周 1-3次, 注射 5次以后改为每月 1次, 注射 5次, 再每两个月 1次, 全程一年 半。 大部分病人两个月内治愈, 少数病重者才需治疗完全程。  Treatment method: Take the patient's two Yingxiang points, respectively, and inject the above formula to get 0. 5ml, 1-3 times a week, after 5 times of injection, change to once a month, 5 times, and once every 2 months. , the whole year and a half. Most patients are cured within two months, and a small number of patients require a full course of treatment.
治疗结果: 治愈 65例, 有效 31例, 无效 4例; 治愈率达到 65%, 有效率 达到 96%。  Treatment results: 65 cases were cured, 31 cases were effective, 4 cases were ineffective; the cure rate reached 65%, and the effective rate reached 96%.
实施例 3  Example 3
一种穴位注射剂, 由以下组分组成: 苯酚在常温下的饱和溶液 1. 5ml, 2% 利多卡因 5ml, 生理盐水 100ml。  An acupoint injection consisting of the following components: a saturated solution of phenol at room temperature 1. 5 ml, 2% lidocaine 5 ml, physiological saline 100 ml.
制备方法: 将 1. 5ml的苯酚在常温下的饱和溶液和 5ml的 2%利多卡因溶 入 100ml的生理盐水中, 混合均匀即可。 临床应用: 治疗颈椎病 Preparation method: 1.5 ml of phenol in a saturated solution at room temperature and 5 ml of 2% lidocaine dissolved in 100 ml of physiological saline, and mixed well. Clinical application: treatment of cervical spondylosis
自 2004年以来, 用以上配方所得的注射药剂治疗颈椎病 60例, 临床观 察 60例, 年龄 21-89岁。  Since 2004, 60 cases of cervical spondylosis have been treated with the above-mentioned injections, and 60 cases have been clinically observed, aged 21-89 years.
治疗方法: 取患者大椎穴和两个椎旁穴及阿是穴, 每个穴位注射 0. 5ml 的药剂, 1次 /每日 -1次 /每周, 五次以后改成每月一次, 共 20-30次, 其 中治愈者可随时停止治疗, 严重者需注射 30次。  Treatment method: Take the patient's Dazhui point and two paravertebral points and Ashi points, each acupuncture point injection of 0. 5ml of the drug, 1 time / daily - 1 time / week, after five times, changed to monthly, a total of 20-30 times, in which the healer can stop treatment at any time, and severe cases need to be injected 30 times.
治疗结果: 治愈 45例, 有效 12例, 无效 3例, 治愈率 75%, 有效率达到 Treatment results: 45 cases were cured, 12 cases were effective, 3 cases were ineffective, the cure rate was 75%, and the effective rate was reached.
95%。 95%.
实施例 4  Example 4
一种穴位注射剂, 由以下组分组成: 苯酚在常温下的饱和溶液 2ml, 2% 利多卡因 5ml, 生理盐水 100ml。  An acupoint injection consisting of the following components: a saturated solution of phenol at room temperature 2 ml, 2% lidocaine 5 ml, and physiological saline 100 ml.
制备方法: 将 2ml的苯酚在常温下的饱和溶液和 5ml的 2%利多卡因溶入 100ml的生理盐水中, 混合均匀即可。  Preparation method: 2 ml of phenol in a saturated solution at room temperature and 5 ml of 2% lidocaine dissolved in 100 ml of physiological saline, and mixed well.
临床应用: 治疗带状疱疹。  Clinical application: Treatment of herpes zoster.
自 2004年以来, 用以上配方的注射药剂治疗了治疗带状疱疹 25例; 临 床观察 25例, 年龄 18-70岁。  Since 2004, 25 cases of herpes zoster have been treated with the above-mentioned injections; 25 cases have been observed clinically, aged 18-70 years.
治疗方法: 取患者阿是穴, 即出疱疹处, 注射以上配方所得的药剂 0. 5-lml o 一次可注射 10个穴位, 即总注射量达到 10-30ml, 每日一次, 治疗 至第 3-4天, 疼痛减轻, 疱疹开始结痂干燥, 至第 7天疱疹处皮肤恢复正常, 便可停药, 至 14天, 疼痛感完全消失。  Treatment method: Take the patient's acupuncture points, that is, the herpes, and inject the above formula into the medicine. 5-lml o can inject 10 acupuncture points at a time, that is, the total injection volume reaches 10-30ml, once a day, treatment to the third -4 days, the pain was relieved, herpes began to dry and dry, and by the 7th day, the skin of the herpes returned to normal, and the drug was stopped. By 14 days, the pain completely disappeared.

Claims

权 利 要 求 书 Claim
1 . -种穴位注射剂, 其特征在于其组成成分包括苯酚在常温下的饱和溶 液和生理盐水, 上述成分的混合比例为 0. 5〜2: 100。 5〜2: 100。 The mixture of a mixture of a mixture of the above-mentioned ingredients is 0. 5~2: 100.
2. 根据权利要求 1所述一种穴位注射剂, 其特征在于所述组成成分还包 括 2%的利多卡因, 常温下的饱和溶液、 生理盐水和 2%的利多卡因混合比例为 0. 5〜2: 100: 5。  2 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 ~2: 100: 5.
3. 根据权利要求 2所述一种穴位注射剂, 其特征在于所述苯酚在常温下 的饱和溶液、 生理盐水和利多卡因的混合比例为 0. 5〜1. 5: 100: 5。  5〜1。 5: 100: 5。 The mixing ratio of the saturated solution of the phenol, the physiological saline and lidocaine is 0. 5~1. 5: 100: 5.
4. 根据权利要求 2所述一种穴位注射剂, 其特征在于所述苯酚在常温下 的饱和溶液、 生理盐水和利多卡因的混合比例为 1 : 100: 5。  4. Acupoint injection according to claim 2, characterized in that the mixing ratio of the saturated solution of phenol at normal temperature, physiological saline and lidocaine is 1:100:5.
PCT/CN2012/000614 2011-05-25 2012-05-07 Acupoint injection WO2012159444A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110136639.9 2011-05-25
CN2011101366399A CN102198091B (en) 2011-05-25 2011-05-25 Acupuncture point injection

Publications (1)

Publication Number Publication Date
WO2012159444A1 true WO2012159444A1 (en) 2012-11-29

Family

ID=44659250

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2012/000614 WO2012159444A1 (en) 2011-05-25 2012-05-07 Acupoint injection

Country Status (2)

Country Link
CN (1) CN102198091B (en)
WO (1) WO2012159444A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021206549A1 (en) * 2020-04-07 2021-10-14 Lin wen zhi Use of phenol in treatment of microbially induced dyspnoea

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111281961A (en) * 2020-03-20 2020-06-16 广州市轻能建材有限公司 Ointment
NL2025295B1 (en) 2020-04-07 2021-10-25 Zhi Lin Wen Use of phenol in treatment of microbially induced dyspnoea
CN114404468A (en) * 2022-03-01 2022-04-29 张焰春 Chinese medicinal injection for treating cancer at acupoints

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1144659A (en) * 1996-07-19 1997-03-12 成都中医药大学附属医院 Good vision injection and its preparation technology
CN1943591A (en) * 2006-06-06 2007-04-11 万立成 Castrating liquid for animal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452351B2 (en) * 2004-04-16 2008-11-18 Kyphon Sarl Spinal diagnostic methods and apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1144659A (en) * 1996-07-19 1997-03-12 成都中医药大学附属医院 Good vision injection and its preparation technology
CN1943591A (en) * 2006-06-06 2007-04-11 万立成 Castrating liquid for animal

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021206549A1 (en) * 2020-04-07 2021-10-14 Lin wen zhi Use of phenol in treatment of microbially induced dyspnoea

Also Published As

Publication number Publication date
CN102198091A (en) 2011-09-28
CN102198091B (en) 2013-02-27

Similar Documents

Publication Publication Date Title
WO2012159444A1 (en) Acupoint injection
CN1327892C (en) External use pain relieving spray liquid
CN103394031B (en) Medicament for treating sciatica
CN103656025B (en) A kind of medical liquor for treating injury
CN103054965B (en) External analgesic plaster for treating arthralgia and preparation method of external analgesic plaster
CN102949502B (en) Scalp folliculitis treatment external application traditional Chinese medicine
CN104288299A (en) Externally-applied traditional Chinese medicinal composition for treating herpes zoster
CN102600343B (en) Traditional Chinese medicinal preparation for treating oral diseases and/or toothache
CN104623379B (en) A kind of pharmaceutical composition for the treatment of Hand-Food-Mouth Disease
CN104547093A (en) Traditional Chinese medicine composition for treating tenosynovitis
CN104383453B (en) Treat the Chinese medicine of craniocerebral injury manic disorder
CN100348239C (en) Traditional Chinese medicine preparation for treating soft tissue pain and preparation method
WO2016180119A1 (en) Topical preparation and the use thereof in preparing drugs for treating lumbar disc herniation
CN106038658A (en) Medicine composition with medicine fire needles and therapeutic application of medicine composition
CN102266408B (en) Use of gardenia extract and borneol effective ingredients in Chinese medicine preparation for intervening in cutaneous prutitus
CN100998604B (en) Traditional Chinese medicine for treat burns and scald and its preparing method
CN108524697A (en) A kind of drug for treating prostatitis and hyperplasia
CN100409877C (en) Chinese medicine preparation for treating hyperosteogeny
CN110420305B (en) Traditional Chinese medicine composition for treating chronic muscle injuries and preparation method thereof
CN107029047A (en) A kind of medicament and its pharmaceutical formulation with analgesia wind-damp dispelling effect promoting blood circulation and removing blood stasis
CN104666420A (en) A medicine for treating rhinitis
CN1887317B (en) Externally applied liniment for treating rheumatic and rheumatoid arthritis and its preparation
CN111281961A (en) Ointment
CN106728618A (en) A kind of Chinese medicine for treating Severe Acute Pancreatitis SAP
CN105902722B (en) Traditional Chinese medicine composition for treating leucoderma as well as preparation method and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12789383

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12789383

Country of ref document: EP

Kind code of ref document: A1